Cargando…
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
The term cancer stem cell (CSC) starts 25 years ago with the evidence that CSC is a subpopulation of tumor cells that have renewal ability and can differentiate into several distinct linages. Therefore, CSCs play crucial role in the initiation and the maintenance of cancer. Moreover, it has been pro...
Autor principal: | Alhabbab, Rowa Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188929/ https://www.ncbi.nlm.nih.gov/pubmed/32391048 http://dx.doi.org/10.3389/fgene.2020.00312 |
Ejemplares similares
-
Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies
por: Alhabbab, Rowa Y.
Publicado: (2022) -
Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
por: Zhou, Wenyujing, et al.
Publicado: (2022) -
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010) -
Engineering chimeric antigen receptor-T cells for cancer treatment
por: Ye, Baixin, et al.
Publicado: (2018) -
Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
por: Chang, Yun, et al.
Publicado: (2022)